miRview® lung is different from other tests. It is very accurate because it uses highly sensitive, cutting-edge technology that measures tiny amounts of material in your tumor sample. The material it measures is called microRNA.
The microRNA measurements tell your doctor whether you have SCLC, carcinoid, squamous NSCLC or non-squamous NSCLC. These measurements are very accurate. In fact, the sensitivity and specificity of this test have been shown to be 93.7% and 98%, respectively¹.

miRview® lung requires a small sample of your tumor tissue. In most cases, a new biopsy is not needed. If you have already had a biopsy or surgery, your doctor probably already has the sample he or she needs.
Once your doctor has the sample, he or she will send it to Rosetta Genomics. Your doctor should receive your test results from Rosetta Genomics within 10 business days.

miRview® lung can tell your doctor if you have SCLC, carcinoid, squamous NSCLC or non-squamous NSCLC. You and your doctor can use this and other information to decide on the best way to move forward in your battle against cancer.

1. Data on file, Rosetta Genomics.